Cadence, Incline Therapeutics, Medicines Co. deal

The Medicines Co. will acquire Incline for $185 million up front plus up to $205 million in milestones. The Medicines Co. will gain exclusive, worldwide rights to Ionsys fentanyl, which

Read the full 301 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE